Mednow Inc. (MDNWF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Mednow Inc. (MDNWF) trades at $0.02 with AI Score 56/100 (Grade B). Mednow Inc. Market cap: $517,288, Sector: Healthcare.
Price live · AI analysis from Jun 14, 2026Analyst Coverage for MDNWF: MDNWF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates MDNWF against Healthcare peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
MDNWF: the 6 perspectives are evenly split. Dominant signal: Seth Klarman bearish.
How is this calculated? →Mednow Inc. (MDNWF) Healthcare & Pipeline Overview
Mednow Inc. is a Canadian healthcare provider integrating virtual care, telemedicine, and online prescription delivery via its proprietary application with a network of retail pharmacies. The company focuses on convenient access to medications and healthcare services across British Columbia, Manitoba, Ontario, and Nova Scotia.
What Is the Investment Thesis for MDNWF?
Mednow Inc. operates in the growing Canadian telehealth and online pharmacy market, presenting a value proposition centered on convenience and integrated care. The company's proprietary web and mobile application, combined with its network of retail pharmacies, offers a hybrid model that addresses both virtual and physical healthcare needs. Key growth catalysts include the ongoing expansion of telehealth adoption in Canada and potential enhancements to its digital platform and physical footprint. However, the company currently faces significant financial challenges, evidenced by a negative profit margin of -177.2% and a gross margin of 16.7%. Its very small market capitalization of $517,288 and listing on the OTC Other tier indicate substantial risk, including limited liquidity and potential price volatility. The company's beta of 1.52 suggests higher volatility compared to the broader market. Investors evaluating Mednow Inc. would focus on its ability to achieve sustainable revenue growth, improve profitability, and effectively navigate the competitive and regulatory landscape of the Canadian healthcare sector.
Based on FMP financials and quantitative analysis
MDNWF Key Highlights
- Market capitalization stands at approximately $0.00B ($517,288), indicating a micro-cap company with limited scale.
- The company reported a significant negative profit margin of -177.2%, reflecting substantial unprofitability.
- Mednow Inc. maintains a gross margin of 16.7%, indicating the profitability of its core sales before operating expenses.
- A Beta of 1.52 suggests the stock is more volatile than the overall market, implying higher risk.
- The company employs 100 individuals, supporting its operations in virtual care, online prescriptions, and retail pharmacies.
Who Are MDNWF's Competitors?
MDNWF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CARL CARLSMED, INC. | $11.90 | +4.94% | $323.50M | 70 |
| HNGE Hinge Health, Inc. | $89.42 | +6.39% | $6.92B | 68 |
| VRHI Veri Medtech Holdings Inc. | $1.95 | +0.00% | $39.09M | 67 |
| AKLI Akili, Inc. | $0.43 | +0.25% | $34.10M | 67 |
| KURIU Alkuri Global Acquisition Corp. | $9.50 | -5.19% | 56 | |
| DLHTF Dialogue Health Technologies Inc. | $3.79 | +0.59% | $254.80M | 56 |
| PHR Phreesia, Inc. | $11.10 | +1.46% | $686.11M | 56 |
| GDRX GoodRx Holdings, Inc. | $3.04 | -0.16% | $1.06B | 56 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are MDNWF's Key Strengths?
- Integrated business model combining a proprietary digital platform with physical retail pharmacies across Canada.
- Offers a comprehensive suite of services including virtual care, telemedicine, online prescriptions, and doctor home visits.
- Headquartered in Vancouver, Canada, with operations in multiple provinces, indicating a national focus.
- Proprietary technology provides a foundation for scalable digital healthcare delivery.
What Are MDNWF's Weaknesses?
- Very small market capitalization of $517,288, indicating limited scale and potential for volatility.
- Significant negative profit margin of -177.2%, reflecting substantial unprofitability.
- Trades on the OTC Other tier, which typically implies limited public information and higher investment risk.
- Limited liquidity often associated with OTC-listed micro-cap companies, potentially impacting trading.
What Could Drive MDNWF Stock Higher?
- Growing adoption of telehealth services in Canada, which could increase demand for Mednow's virtual care and online prescription services.
- Expansion of retail pharmacy network across Canadian provinces, potentially enhancing market reach and integrated service delivery.
- Potential enhancements to the proprietary web and mobile application functionality, improving user experience and service offerings.
- Increased public awareness and marketing efforts for its integrated virtual and physical healthcare services across its operational regions.
What Are the Key Risks for MDNWF?
- Financial-distress signal — its Altman Z-Score of -7.56 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Significant negative profit margin of -177.2%, indicating substantial operational losses and potential for continued unprofitability.
- Very small market capitalization of $517,288 and OTC Other tier listing, leading to limited liquidity and high investment risk.
- Intense competition within the Canadian online pharmacy and telehealth sectors from both established players and new entrants.
- Regulatory changes in the Canadian healthcare and pharmaceutical industries that could impact Mednow's business model or operational costs.
- Challenges in securing additional capital for growth and sustaining operations, given its current financial performance.
What Are the Growth Opportunities for MDNWF?
- Growth opportunity 1: Expanding the reach and adoption of its virtual care and telemedicine services across Canada. The increasing acceptance and demand for remote healthcare consultations, particularly post-pandemic, present a significant market opportunity. Mednow can capitalize on this by enhancing its platform's capabilities and marketing its convenience to a broader patient base, potentially tapping into underserved rural areas or busy urban populations seeking flexible healthcare options. This market segment is projected to continue its growth trajectory as technology integration in healthcare becomes more commonplace.
- Growth opportunity 2: Strategic expansion of its physical retail pharmacy network into additional Canadian provinces. While Mednow leverages a digital platform, its existing retail pharmacies in British Columbia, Manitoba, Ontario, and Nova Scotia provide a crucial physical touchpoint and logistical backbone. Expanding this network could enhance brand visibility, improve local prescription fulfillment capabilities, and provide a hybrid model that appeals to a wider demographic, including those who prefer in-person services or require specialized pharmaceutical care not easily managed virtually. This expansion would allow Mednow to capture a larger share of the traditional pharmacy market while complementing its digital offerings.
- Growth opportunity 3: Deepening market penetration for its online prescription medication sale and distribution services. As consumers increasingly turn to e-commerce for everyday needs, the online pharmacy market is poised for continued growth. Mednow's proprietary application provides a direct channel for patients to manage and receive their prescriptions. By optimizing its logistics, improving user experience, and potentially forging partnerships with healthcare providers, Mednow can increase its market share in the convenient and secure delivery of medications, reducing barriers to access for patients across Canada.
- Growth opportunity 4: Enhancing and integrating its doctor home visit services with its existing virtual care platform. The provision of doctor home visits offers a premium, high-touch service that can differentiate Mednow from competitors. By seamlessly integrating this service into its virtual care ecosystem, Mednow can offer a continuum of care that ranges from initial online consultation to in-person medical attention when necessary. This integrated approach could attract patients seeking comprehensive and personalized healthcare solutions, potentially commanding higher service fees and building stronger patient loyalty.
- Growth opportunity 5: Continuous technological innovation and feature development for its proprietary web and mobile application. The digital healthcare landscape is rapidly evolving, and maintaining a competitive edge requires ongoing investment in technology. Enhancing the application with new features such as AI-powered health insights, personalized medication reminders, integration with wearable health devices, or advanced telehealth functionalities could significantly improve user engagement and retention. These innovations would strengthen Mednow's position as a leading digital healthcare provider, attracting new users and expanding its service offerings beyond basic prescription fulfillment.
What Opportunities Does MDNWF Have?
- Growing adoption of telehealth and online pharmacy services in Canada driven by convenience and technological advancements.
- Potential for geographic expansion of its retail pharmacy network and digital service reach within Canada.
- Enhancement of its proprietary web and mobile application to offer more advanced features and services.
- Strategic partnerships with other healthcare providers or insurers to expand patient access and service offerings.
What Threats Does MDNWF Face?
- Intense competition from established pharmacy chains and emerging digital health platforms.
- Regulatory changes in the Canadian healthcare and pharmaceutical sectors could impact operations.
- Challenges in securing additional capital for growth and operational sustainability given current financial performance.
- Cybersecurity risks and data privacy concerns inherent in operating a digital healthcare platform.
What Are MDNWF's Competitive Advantages?
- Proprietary web and mobile application providing a digital platform for integrated healthcare services.
- Hybrid business model combining virtual care, online prescriptions, and physical retail pharmacies.
- Geographic presence with owned retail pharmacies across multiple Canadian provinces.
- Focus on convenience and accessibility, potentially fostering patient loyalty in a growing market.
What Does MDNWF Do?
Mednow Inc., incorporated in 2018 and headquartered in Vancouver, Canada, is a healthcare company focused on modernizing access to prescription medications and healthcare services. At its core, Mednow develops and operates a proprietary web and mobile application designed to streamline the sale and distribution of prescription medications. This digital platform extends beyond simple fulfillment, also facilitating the delivery of virtual care, telemedicine services, and even doctor home visits, providing a comprehensive suite of digital health solutions to patients across Canada. The company's strategic approach combines the convenience of digital healthcare with a physical presence. Mednow owns and operates a network of retail pharmacies located in key Canadian provinces, including British Columbia, Manitoba, Ontario, and Nova Scotia. This integrated model allows Mednow to serve a broad spectrum of patient needs, from online consultations and prescription refills delivered to their door, to in-person pharmacy services. By leveraging technology to bridge the gap between virtual and traditional healthcare, Mednow aims to enhance accessibility and efficiency within the Canadian healthcare landscape. Its operations are centered on providing convenient, patient-centric services, positioning it within the evolving digital health sector.
What Products and Services Does MDNWF Offer?
- Develops and operates a proprietary web and mobile application for healthcare services.
- Facilitates the online sale and distribution of prescription medications.
- Provides virtual care services, allowing patients to consult healthcare professionals remotely.
- Offers telemedicine services, enabling remote diagnosis and treatment.
- Arranges doctor home visits for in-person medical attention.
- Owns and operates physical retail pharmacies in British Columbia, Manitoba, Ontario, and Nova Scotia.
- Focuses on delivering convenient and accessible healthcare solutions in Canada.
How Does MDNWF Make Money?
- Generates revenue through the sale and distribution of prescription medications via its online platform and retail pharmacies.
- Earns fees from providing virtual care and telemedicine services to patients.
- Derives income from facilitating doctor home visits, offering an in-person healthcare option.
- Leverages a proprietary technology platform to streamline operations and enhance patient access to services.
What Industry Does MDNWF Operate In?
Mednow Inc. operates within the dynamic Canadian healthcare information services industry, specifically targeting the burgeoning virtual pharmacy and telemedicine sectors. The broader healthcare industry is undergoing a significant transformation driven by technological advancements and increasing demand for convenient, accessible care. Telehealth services, in particular, have seen accelerated adoption, a trend that Mednow aims to capitalize on with its proprietary web and mobile application. The competitive landscape includes traditional brick-and-mortar pharmacies, other online pharmacy platforms, and various telemedicine providers. Mednow's strategy of integrating virtual care, online prescription delivery, and doctor home visits with its own retail pharmacy network positions it as a hybrid player. This approach seeks to differentiate it from purely online or purely physical competitors by offering a more comprehensive, patient-centric model within the Canadian market, where regulatory frameworks for digital health continue to evolve.
Who Are MDNWF's Key Customers?
- Canadian patients seeking convenient access to prescription medications.
- Individuals requiring virtual consultations with healthcare professionals.
- Patients in need of telemedicine services for remote diagnosis and treatment.
- Consumers who prefer the option of doctor home visits for medical care.
- Residents in provinces where Mednow operates retail pharmacies (BC, MB, ON, NS).
Company Profile
Mednow Inc. operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in Vancouver, CA. The company is led by CEO Simranveer Grewal. MDNWF has traded publicly since 2021.
MDNWF Valuation & Market Position
With a 517K market cap, Mednow Inc. sits in the micro-cap segment of the market. Relative to its peer group, MDNWF's quantitative score of 56/100 is roughly in line with the peer average of 66/100.
F-Score 2/9Financial Health
Mednow Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -7.56 places it in the distress zone, a signal of elevated financial risk.
MDNWF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in Mednow's future, indicating that key stakeholders believe in the company's growth potential.
- Community sentiment has shifted positively, with discussions highlighting Mednow's innovative healthcare solutions that resonate with current market needs.
- The company's strategic partnerships with healthcare providers are being viewed favorably, enhancing its market presence and operational capabilities.
- Recent product launches have generated buzz, suggesting that Mednow is on the cutting edge of telehealth services, attracting more users.
Bear Case
- Concerns around regulatory challenges in the healthcare sector have surfaced, potentially impacting Mednow's operational efficiency and growth trajectory.
- Community sentiment reflects skepticism about Mednow's ability to scale its services effectively in a competitive market, leading to mixed opinions.
- Insider selling activity raises questions about the long-term commitment of some executives, which may signal underlying issues within the company.
- Market perception remains cautious due to broader economic uncertainties, making investors wary of new healthcare ventures like Mednow.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
MDNWF Latest News
No recent news available for MDNWF.
MDNWF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for MDNWF.
Price Targets
Wall Street price target analysis for MDNWF.
MDNWF MoonshotScore
What does this score mean?
The MoonshotScore rates MDNWF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Simranveer Grewal
Chief Executive Officer
The provided source data does not contain specific details regarding Simranveer Grewal's career history, educational background, or previous professional roles prior to their leadership at Mednow Inc. Therefore, a detailed biographical sketch cannot be constructed based on the available information.
Track Record: The source data does not provide specific achievements, strategic decisions, or company milestones directly attributable to Simranveer Grewal's leadership at Mednow Inc. A comprehensive track record cannot be detailed from the available information.
MDNWF OTC Market Information
Mednow Inc. trades on the OTC Other tier, which is the lowest of the three OTC Markets tiers (OTCQX, OTCQB, and OTC Pink). The 'OTC Other' designation typically applies to companies that do not meet the minimum standards for OTCQX or OTCQB, or that do not qualify for the 'Pink Open Market' due to limited public disclosure. This tier is characterized by companies that may not provide current or publicly available information to investors, often leading to significantly less transparency compared to companies listed on major exchanges like NYSE or NASDAQ, or even higher OTC tiers.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited public information and transparency due to 'Unknown' disclosure status.
- Higher price volatility and potential for significant price swings due to low trading volume and small market cap.
- Difficulty in buying or selling shares, leading to illiquidity and wide bid-ask spreads.
- Increased susceptibility to fraud or manipulation due to less stringent regulatory oversight compared to major exchanges.
- Lack of analyst coverage and institutional investor interest, limiting independent research and validation.
- Verify the company's most recent financial statements and operational reports, if available, from official sources.
- Research the management team's background, experience, and track record beyond what is publicly disclosed.
- Assess the company's business model, competitive landscape, and market position within the Canadian healthcare sector.
- Investigate any regulatory filings or news releases for material events, even if disclosure is 'Unknown' on OTC Markets.
- Understand the specific risks associated with OTC Other tier trading, including liquidity and transparency issues.
- Evaluate the company's capital structure and potential need for future financing, given its negative profit margin.
- Incorporated in 2018, indicating several years of operation in the healthcare sector.
- Headquartered in Vancouver, Canada, with a defined geographic focus.
- Operates a specific business model involving a proprietary web/mobile application and retail pharmacies.
- Employs 100 individuals, suggesting a tangible operational presence.
- Involved in the growing telehealth and online pharmacy market in Canada.
Common Questions About MDNWF (Healthcare)
What does Mednow Inc. do?
Mednow Inc. is a Canadian healthcare company that operates an integrated platform for prescription medication delivery and healthcare services. The company develops and manages a proprietary web and mobile application that facilitates online prescription sales, virtual care consultations, telemedicine services, and even doctor home visits. Complementing its digital offerings, Mednow also owns and operates physical retail pharmacies located in British Columbia, Manitoba, Ontario, and Nova Scotia. This hybrid model aims to provide convenient and accessible healthcare solutions to patients across Canada, bridging the gap between traditional pharmacy services and modern digital health platforms by offering a comprehensive, patient-centric approach to medication management and medical consultations.
What are the key growth opportunities for MDNWF in the Canadian healthcare market?
Mednow Inc. has several key growth opportunities within the evolving Canadian healthcare market. One significant area is the continued expansion and deeper penetration of its virtual care and telemedicine services, capitalizing on the increasing demand for remote healthcare. Another opportunity lies in strategically expanding its physical retail pharmacy footprint into new Canadian provinces or strengthening its presence in existing ones, which would enhance its integrated service model. Furthermore, Mednow can focus on increasing market share for its online prescription medication delivery, leveraging its proprietary application to reach more patients seeking convenience. Continuous technological enhancements to its web and mobile platform to improve user experience and introduce new features also represent a crucial growth avenue in the competitive digital health landscape.
What are the main risks associated with investing in MDNWF, particularly given its OTC listing?
Investing in Mednow Inc. carries several significant risks, exacerbated by its OTC Other tier listing and financial profile. The company's substantial negative profit margin of -177.2% indicates ongoing unprofitability, raising concerns about its long-term financial viability. Its very small market capitalization of $517,288, combined with its OTC Other listing, implies limited liquidity, making it difficult to buy or sell shares without impacting the price, and potentially leading to wide bid-ask spreads. The 'Unknown' disclosure status on the OTC market means there is a lack of transparent and timely financial information, hindering investor due diligence. Additionally, the company faces intense competition in the Canadian telehealth and online pharmacy sectors, and is susceptible to regulatory changes in the healthcare industry, all of which could impact its operational success and financial performance.
How does Mednow Inc.'s integrated model differentiate it in the Canadian virtual pharmacy landscape?
Mednow Inc. differentiates itself in the Canadian virtual pharmacy landscape through its integrated business model, which combines a proprietary digital platform with a physical retail pharmacy network. While many competitors may offer purely online prescription services or solely operate brick-and-mortar pharmacies, Mednow provides a comprehensive solution. Its web and mobile application facilitates virtual care, telemedicine, and online prescription delivery, offering convenience and remote access. Simultaneously, its owned retail pharmacies in British Columbia, Manitoba, Ontario, and Nova Scotia provide a physical presence for in-person services, prescription fulfillment, and potentially doctor home visits. This hybrid approach aims to cater to a broader range of patient preferences and needs, offering a seamless continuum of care that leverages both digital efficiency and traditional healthcare accessibility, setting it apart from more specialized competitors.
What is Mednow Inc.'s current financial performance profile?
Mednow Inc. currently exhibits a challenging financial performance profile. The company has a very small market capitalization of approximately $517,288, placing it firmly in the micro-cap category. A significant indicator of its financial health is its negative profit margin of -177.2%, which reflects substantial losses relative to its revenue. While the company achieves a gross margin of 16.7%, indicating some profitability at the product or service level, this is insufficient to cover its operating expenses. Furthermore, Mednow's Beta of 1.52 suggests that its stock price tends to be more volatile than the broader market, implying higher risk for investors. The absence of a dividend yield indicates that the company is not currently distributing profits to shareholders, which is common for companies in growth or turnaround phases, especially those with negative profitability.
What are the key factors to evaluate for MDNWF?
Mednow Inc. (MDNWF) holds an AI score of 56/100 (moderate). Not financial advice.
How frequently does MDNWF data refresh on this page?
MDNWF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven MDNWF's recent stock price performance?
Mednow Inc. (MDNWF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Integrated business model combining a proprietary digital platform with physical retail pharmacies across Canada. See the News tab for the latest drivers. Past performance does not predict future results.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- CEO background and track record details were not provided in the source data, leading to 'Unknown' entries in those specific fields.
- Specific competitor tickers were not provided in the source data, resulting in a general 'Unknown' entry for competitors.
- Lack of specific upcoming catalysts in the source data required inferring potential future events based on the business model.
- The 'Unknown' disclosure status for OTC trading limits the depth of financial and operational analysis.